We are live on ! Find out more
EV

Eclipse Ventures Portfolio holdings

AUM $2.57B
This Fund
S&P 500
This Quarter Est. Return
+4.85%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.69M
AUM Growth
-$114M
Cap. Flow
-$114M
Cap. Flow %
-1,181.58%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ENVX icon
Enovix
ENVX
+$113M
2
LHDX
Lucira Health, Inc. Common Stock
LHDX
+$1.43M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OWLT icon
1
Owlet
OWLT
$146M
$9.69M 100%
2,035,167
ENVX icon
2
Enovix
ENVX
$737M
-8,666,581
Closed -$113M
LHDX
3
DELISTED
Lucira Health, Inc. Common Stock
LHDX
-6,223,795
Closed -$1.43M

Similar funds

Eclipse Ventures's Q2 2023 Portfolio in Review

As of Q2 2023, Eclipse Ventures held 3 positions worth $9.69M, down 92% from $124M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Eclipse Ventures withdrew a net $114M in Q2 2023, closing 2 positions. Its most notable exit was Enovix, an estimated $113M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 8.6% a quarter earlier, followed by Industrials.

  • Eclipse Ventures fully exited Enovix in Q2 2023, selling an estimated $113M.
  • Eclipse Ventures's ten largest holdings make up 100% of its $9.69M portfolio in Q2 2023.
  • Eclipse Ventures opened 0 new positions and closed 2 in Q2 2023.
  • Eclipse Ventures's portfolio value fell 92% quarter-over-quarter to $9.69M.

Based on Eclipse Ventures's 13F filing for Q2 2023, filed 10 Aug 2023.